Novavax vaccine over 90% effective in U.S. trial
2 years ago
1.6K
Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer McCarthy reports.
Loading 10 comments...
-
0:30
Reuters
2 hours agoDozens of pro-Palestinian protestors arrested at NYU
15211 -
0:35
Newsy
3 years agoNovavax Vaccine Trial Gets 30,000 Volunteers
7195 -
1:47
Reuters
3 years agoPfizer says vaccine safe, effective on adolescents in trial
2902 -
2:24
KJRH
3 years agoTulsa woman describes experience in Novavax coronavirus vaccine trial
2.18K4 -
1:49
WFTS
3 years agoNovavax opens Phase 3 trial for COVID-19 vaccine candidate
1752 -
2:41
WMAR
3 years agoPfizer: trial shows vaccine is safe, effective in kids ages 12-15
1471 -
1:53
WFTS
2 years agoPinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial
66 -
0:13
KTNV
3 years agoReport: Moderna vaccine 90% effective for 6 months
92 -
2:11
WEWS
2 years agoModerna trial says COVID-19 vaccine effective in kids 12-15 years old
23 -
0:26
Newsy
2 years agoNovavax Study Finds Shot About 90% Effective
1.02K4
